Ventricular tachycardia adverse event reports that record this term

Kind of term: MedDRA preferred term
Plain meaning: a fast rhythm from the lower heart chambers

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on 2 Oct 2026. The data have the reports that FDA received through 30 Jun 2026.

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.
Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on 2 Oct 2026.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports on file

From January 2004 to June 2026, FDA received 16,170 adverse event reports that record the MedDRA preferred term Ventricular tachycardia. In plain words, the term means: a fast rhythm from the lower heart chambers. The person who codes a report selects the term that agrees best with the description of the reporter.

FDA received 902 reports in the 12 months to June 2026 and 811 in the 12 months before. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

By reports in the 12 months to June 2026, this term was number 657 of 1,436 reaction terms with a page. Of the 1,332,454 drug reports that FDA received in the 12 months to June 2026, 902 (0.1%) record this term. Reports for male patients were 49.1% of the reports that record this term and 34.6% of all drug reports.

The number of people who use the product is not in the data. A count is not a rate.

MedDRA

The Medical Dictionary for Regulatory Activities. The person who codes a report selects the preferred term that agrees best with the description of the reporter. FDA does not publish the description.

Plain meaning

A fast rhythm from the lower heart chambers. The words are from the fixed dictionary of this site. They add nothing to a report.

Data version

openFDA FAERS release of 29 Oct 2026. Reports received through 30 Jun 2026.

Drugs in these reports

The table has the 129 drug pages with 50 or more reports that record this term. The rows are in order of name. A drug page with fewer reports for this term is not in the table. The counts are the counts that the site keeps for each reaction term, and a count can be lower than the count of FDA.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Drugs that the reports with the term Ventricular tachycardia name as a suspect product, in order of name
Drug	Class	Reports with this term
Acetaminophen		58
Activase		89
Allopurinol	Xanthine oxidase inhibitor	91
Alprazolam	Benzodiazepine	87
Amiodarone		518
Amiodarone hcl		180
Amiodarone hydrochloride	Antiarrhythmic	108
Amitriptyline		102
Apixaban	Factor Xa inhibitor	440
Aspirin	Nonsteroidal anti-inflammatory drug	211
Astrazeneca Covid-19 Vaccine		343
Atorvastatin		105
Avandamet		54
Avandia		314
Azithromycin	Macrolide antimicrobial	85
Azithromycin Anhydrous		70
Bisoprolol	beta-Adrenergic blocker	324
Bisoprolol fumarate	beta-Adrenergic blocker	371
Bupropion	Aminoketone	193
Bupropion hydrochloride	Aminoketone	132
Candesartan	Angiotensin 2 receptor blocker	275
Candesartan cilexetil	Angiotensin 2 receptor blocker	158
Capecitabine	Nucleoside metabolic inhibitor	61
Carboplatin	Platinum-based drug	83
Carvedilol	alpha-Adrenergic blocker	93
Cetirizine	Histamine-1 receptor antagonist	146
Cetirizine hydrochloride	Histamine-1 receptor antagonist	252
Ciprofloxacin	Fluoroquinolone antibacterial	75
Cisplatin	Platinum-based drug	59
Citalopram	Serotonin reuptake inhibitor	146
Citalopram hydrobromide	Serotonin reuptake inhibitor	64
Clarithromycin	Macrolide antimicrobial	89
Clonazepam	Benzodiazepine	77
Clopidogrel	P2Y12 platelet inhibitor	114
Cyclophosphamide	Alkylating drug	113
Cytarabine	Nucleoside metabolic inhibitor	82
Dapagliflozin	Sodium-Glucose cotransporter 2 inhibitor	439
Dexamethasone	Corticosteroid	127
Diazepam	Benzodiazepine	67
Digoxin	Cardiac glycoside	854
Diphenhydramine	Histamine-1 receptor antagonist	84
Dofetilide	Antiarrhythmic	50
Doxorubicin	Anthracycline topoisomerase inhibitor	63
Eliquis	Factor Xa inhibitor	78
Entresto	Angiotensin 2 receptor blocker	413
Epinephrine	Catecholamine	180
Eplerenone	Aldosterone antagonist	83
Escitalopram	Serotonin reuptake inhibitor	74
Esomeprazole	Proton pump inhibitor	349
Esomeprazole magnesium	Proton pump inhibitor	100
Felodipine	Dihydropyridine calcium channel blocker	384
Fentanyl	Opioid agonist	120
Flecainide		215
Flecainide acetate	Antiarrhythmic	73
Fluconazole	Azole antifungal	93
Fluorouracil	Nucleoside metabolic inhibitor	104
Fluoxetine	Serotonin reuptake inhibitor	89
Furosemide	Loop diuretic	322
Gabapentin	Anti-epileptic agent	58
Haloperidol	Typical antipsychotic	58
Heparin		67
Heparin sodium	Anti-coagulant	64
Humira		120
Hydrochlorothiazide	Thiazide diuretic	448
Hydroxychloroquine	Antimalarial	138
Hydroxyzine	Antihistamine	56
Imbruvica	Kinase inhibitor	71
Imdur		357
Isosorbide dinitrate	Nitrate vasodilator	370
Isosorbide mononitrate	Nitrate vasodilator	389
Lacosamide		73
Lamotrigine	Anti-epileptic agent	101
Lansoprazole	Proton pump inhibitor	444
Levetiracetam		156
Levofloxacin	Fluoroquinolone antibacterial	109
Levothyroxine		103
Levothyroxine sodium	l-Thyroxine	369
Lidocaine	Amide local anesthetic	165
Linagliptin	Dipeptidyl peptidase 4 inhibitor	404
Lisinopril	Angiotensin converting enzyme inhibitor	53
Loperamide		244
Loperamide hydrochloride	Opioid agonist	107
Lorazepam	Benzodiazepine	58
Metformin	Biguanide	173
Methadone	Opioid agonist	130
Methotrexate	Folate analog metabolic inhibitor	108
Methylprednisolone	Corticosteroid	78
Metoprolol	beta-Adrenergic blocker	219
Metoprolol succinate	beta-Adrenergic blocker	51
Metoprolol tartrate	beta-Adrenergic blocker	75
Mirtazapine		78
Multaq	Antiarrhythmic	89
Mycophenolate mofetil	Antimetabolite immunosuppressant	76
Naproxen	Nonsteroidal anti-inflammatory drug	380
Norepinephrine	Catecholamine	69
Olanzapine	Atypical antipsychotic	119
Omeprazole	Proton pump inhibitor	153
Ondansetron	Serotonin-3 receptor antagonist	304
Oxaliplatin	Platinum-based drug	76
Pantoprazole	Proton pump inhibitor	120
Perindopril		66
Potassium chloride	Osmotic laxative	53
Pradaxa	Direct thrombin inhibitor	66
Prednisolone	Corticosteroid	77
Prednisone	Corticosteroid	194
Propofol	General anesthetic	177
Propranolol	beta-Adrenergic blocker	86
Quetiapine	Atypical antipsychotic	154
Ramipril	Angiotensin converting enzyme inhibitor	138
Revlimid	Thalidomide analog	75
Rituximab	CD20-directed cytolytic antibody	109
Rosuvastatin	HMG-CoA reductase inhibitor	95
Sacubitril valsartan		94
Sertraline	Serotonin reuptake inhibitor	113
Sevoflurane	General anesthetic	98
Simvastatin	HMG-CoA reductase inhibitor	382
Sotalol	Antiarrhythmic	86
Sotalol hydrochloride	Antiarrhythmic	89
Spironolactone	Aldosterone antagonist	136
Tacrolimus	Calcineurin inhibitor immunosuppressant	83
Tikosyn	Antiarrhythmic	100
Torsemide	Loop diuretic	72
Tracleer	Endothelin receptor antagonist	52
Trazodone		57
Vancomycin	Glycopeptide antibacterial	54
Venlafaxine	Serotonin and norepinephrine reuptake inhibitor	189
Venlafaxine hydrochloride	Serotonin and norepinephrine reuptake inhibitor	58
Vioxx		288
Warfarin	Vitamin K antagonist	52

The page of each drug has the count of each reaction term in its reaction lookup.

Drug classes in these reports

The table has the 51 pharmacologic classes with 100 or more reports that record this term. The rows are in order of name.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Pharmacologic classes of the drugs that the reports with the term Ventricular tachycardia name, in order of name
Class	Reports with this term
Aldosterone antagonist	258
Alkylating drug	151
alpha-Adrenergic blocker	108
Amide local anesthetic	248
Aminoketone	376
Angiotensin 2 receptor blocker	962
Angiotensin converting enzyme inhibitor	267
Anthracycline topoisomerase inhibitor	107
Anti-epileptic agent	270
Antiarrhythmic	678
Antimalarial	208
Atypical antipsychotic	545
Azole antifungal	172
Benzodiazepine	372
beta-Adrenergic blocker	1,221
Biguanide	247
Calcineurin inhibitor immunosuppressant	134
Cardiac glycoside	861
Catecholamine	287
CD20-directed cytolytic antibody	140
Corticosteroid	545
Dihydropyridine calcium channel blocker	415
Dipeptidyl peptidase 4 inhibitor	428
Endothelin receptor antagonist	123
Factor Xa inhibitor	586
Fluoroquinolone antibacterial	237
Folate analog metabolic inhibitor	141
General anesthetic	326
Histamine-1 receptor antagonist	542
HMG-CoA reductase inhibitor	594
Kinase inhibitor	362
l-Thyroxine	391
Loop diuretic	440
Macrolide antimicrobial	192
Nitrate vasodilator	785
Nonsteroidal anti-inflammatory drug	671
Nucleoside metabolic inhibitor	314
Opioid agonist	515
Osmotic laxative	109
P2Y12 platelet inhibitor	222
Platinum-based drug	218
Programmed death Receptor-1 blocking antibody	155
Proton pump inhibitor	1,223
Serotonin and norepinephrine reuptake inhibitor	308
Serotonin reuptake inhibitor	670
Serotonin-3 receptor antagonist	321
Sodium-Glucose cotransporter 2 inhibitor	504
Thalidomide analog	133
Thiazide diuretic	448
Tumor necrosis factor blocker	103
Xanthine oxidase inhibitor	101

A class with many reports in all has many reports for almost every term.

Reports by month

Reports that record Ventricular tachycardia, by month, five years to June 2026

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Patients in these reports

Age of the patient in the reports that record Ventricular tachycardia
Age	Reports	Share
Under 2	119	0.7%
2 to 11	275	1.7%
12 to 17	382	2.4%
18 to 44	2,894	17.9%
45 to 64	4,252	26.3%
65 to 74	2,746	17%
75 and over	2,225	13.8%
Age not given	3,277	20.3%

Sex of the patient in the reports that record Ventricular tachycardia
Sex	Reports	Share
Female	6,691	41.4%
Male	7,942	49.1%
Unknown or not given	1,537	9.5%

Age and sex are as the report gives them. 49.7% of these reports give the United States as the country.

Terms near this one

These are the next terms in the A to Z list. The links are for navigation.

Official pages

MedWatch Online Voluntary Reporting FormThe online form of FDA for a voluntary report.
MedWatch: The FDA Safety Information and Adverse Event Reporting ProgramThe page of the FDA program that receives reports about drugs and devices.
FDA Adverse Event Monitoring System (AEMS) Public DashboardThe public dashboard of FDA for adverse event reports on drugs and biologics.

The site checked these addresses on 2 Oct 2026. The links open in a new tab.

Cite this page

Reported Reactions. Ventricular tachycardia: adverse event reports that record this term. https://reportedreactions.com/reaction/ventricular-tachycardia/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of 29 Oct 2026. Reports received through 30 Jun 2026.

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The count has the reports with each spelling of one MedDRA preferred term. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

What does Ventricular tachycardia mean in an adverse event report?

In plain words: a fast rhythm from the lower heart chambers. It is a MedDRA preferred term. FDA codes the description of a reporter with the MedDRA dictionary. The openFDA files do not have the description itself, and this site does not show it.

Does a drug in the table mean that the drug was responsible for this reaction?

No. FDA says:

No individual drug is connected to any individual reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

When a report lists multiple drugs and multiple reactions, there is no way to conclude from the data therein that a given drug is responsible for a given reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

What does this page tell a person who has this symptom?

This page gives counts of reports. It cannot assess a person. A pharmacist or a clinician can assess a person.

If this is a medical emergency, please call 911.
Source: FDA, MedWatch Online Voluntary Reporting Form. The site read the page on 2 Oct 2026.

To the top of the page